Patent ID: 9655915
Date: 2017-05-23
CPC Classifications: A61K,A61P,C07F,C07H

Claim:
1. A method of treatment of cancer comprising administering to a Homo sapiens patient in need of such treatment an effective dose of 5-fluoro-2′-deoxyuridine-5′-O-[1-naphthyl (benzoxy- L -alaninyl)] phosphate (CPF373), or a pharmaceutically acceptable salt thereof, wherein the patient has developed or has the potential to develop resistance in tumour cells with respect to the activity of 5-fluoracil (5-FU) or 5-fluoro-2′-deoxyuridine (5-FdUrd), and wherein the cancer is selected from gastrointestinal cancer, leukemia, lymphoma, pancreatic cancer, prostate cancer, lung cancer, breast cancer, cervical cancer, head and neck cancer, and ovarian cancer.